Table 2.
Differences between different-threshold and FWHM methods
| LGEDL | LGEO | ||||||
|---|---|---|---|---|---|---|---|
| t | p | t | p | ||||
| 2SD Parea vs. 3SD Parea | 41.32 ± 12.78 vs. 39.83 ± 16.58 | 1.454 | >0.05 | 32.81 ± 12.59 vs. 31.41 ± 16.07 | 1.808 | >0.05 | |
| 2SD Parea vs. 4SD Parea | 41.32 ± 12.78 vs. 30.57 ± 15.25 | 8.390 | < 0.05 | 32.81 ± 12.59 vs. 23.96 ± 12.79 | 7.644 | < 0.05 | |
| 2SD Parea vs. 5SD Parea | 41.32 ± 12.78 vs. 28.53 ± 12.92 | 12.072 | < 0.05 | 32.81 ± 12.59 vs. 19.98 ± 12.73 | 11.836 | < 0.05 | |
| 2SD Parea vs. FWHM Parea | 41.32 ± 12.78 vs. 17.25 ± 11.22 | 10.567 | < 0.05 | 32.81 ± 12.59 vs. 17.18 ± 11.12 | 7.375 | < 0.05 | |
| 3SD Parea vs. 4SD Parea | 39.83 ± 16.58 vs. 30.57 ± 15.25 | 10.342 | < 0.05 | 31.41 ± 16.07 vs. 23.96 ± 12.79 | 7.468 | < 0.05 | |
| 3SD Parea vs. 5SD Parea | 39.83 ± 16.58 vs. 28.53 ± 12.92 | 10.963 | < 0.05 | 31.41 ± 16.07 vs. 19.98 ± 12.73 | 14.059 | < 0.05 | |
| 3SD Parea vs. FWHM Parea | 39.83 ± 16.58 vs. 17.25 ± 11.22 | 8.878 | < 0.05 | 31.41 ± 16.07 vs. 17.18 ± 11.12 | 5.695 | < 0.05 | |
| 4SD Parea vs. 5SD Parea | 30.57 ± 15.25 vs. 28.53 ± 12.92 | 2.142 | < 0.05 | 23.96 ± 12.79 vs. 19.98 ± 12.73 | 5.474 | < 0.05 | |
| 4SD Parea vs. FWHM Parea | 30.57 ± 15.25 vs. 17.25 ± 11.22 | 5.733 | < 0.05 | 23.96 ± 12.79 vs. 17.18 ± 11.12 | 3.048 | < 0.05 | |
| 5SD Parea vs. FWHM Parea | 28.53 ± 12.92 vs. 17.25 ± 11.22 | 4.964 | < 0.05 | 19.98 ± 12.73 vs. 17.18 ± 11.12 | 1.314 | >0.05 | |
Note: LGEDL, deep learning-based reconstruction late gadolinium enhancement; LGEO, conventionally constructed late gadolinium enhancement; Parea, percentage of myocardial enhancement area; FWHM, full width at half maximum